ATE412761T1 - Methode um rekombinante proteine in cho zellen zu exprimieren - Google Patents
Methode um rekombinante proteine in cho zellen zu exprimierenInfo
- Publication number
- ATE412761T1 ATE412761T1 AT03765075T AT03765075T ATE412761T1 AT E412761 T1 ATE412761 T1 AT E412761T1 AT 03765075 T AT03765075 T AT 03765075T AT 03765075 T AT03765075 T AT 03765075T AT E412761 T1 ATE412761 T1 AT E412761T1
- Authority
- AT
- Austria
- Prior art keywords
- cho cells
- recombinant proteins
- express recombinant
- express
- enhancing
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 238000001890 transfection Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0216648.6A GB0216648D0 (en) | 2002-07-18 | 2002-07-18 | Method of expressing recombinant protein in CHO cells |
| PCT/EP2003/007946 WO2004009823A1 (en) | 2002-07-18 | 2003-07-21 | Method of expressing recombinant protein in cho cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE412761T1 true ATE412761T1 (de) | 2008-11-15 |
Family
ID=9940670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03765075T ATE412761T1 (de) | 2002-07-18 | 2003-07-21 | Methode um rekombinante proteine in cho zellen zu exprimieren |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20060003405A1 (de) |
| EP (1) | EP1525320B1 (de) |
| CN (1) | CN1296486C (de) |
| AT (1) | ATE412761T1 (de) |
| AU (2) | AU2003251434B2 (de) |
| CA (2) | CA2489016C (de) |
| DE (1) | DE60324430D1 (de) |
| DK (1) | DK1525320T3 (de) |
| ES (1) | ES2314248T3 (de) |
| GB (1) | GB0216648D0 (de) |
| PT (1) | PT1525320E (de) |
| SI (1) | SI1525320T1 (de) |
| WO (1) | WO2004009823A1 (de) |
Families Citing this family (86)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0216648D0 (en) * | 2002-07-18 | 2002-08-28 | Lonza Biologics Plc | Method of expressing recombinant protein in CHO cells |
| GB0319451D0 (en) * | 2003-08-19 | 2003-09-17 | Lonza Biologics Plc | Tropolone assay |
| PT1730191E (pt) | 2004-03-30 | 2011-10-04 | Glaxo Group Ltd | Imunoglobulina que se liga a hosm |
| TWI307630B (en) | 2004-07-01 | 2009-03-21 | Glaxo Group Ltd | Immunoglobulins |
| WO2006111387A2 (en) * | 2005-04-22 | 2006-10-26 | Lonza Biologics Plc. | Mammalian expression vector comprising the mcmv promoter and first intron of hcmv major immediate early gene |
| EP1915394B1 (de) * | 2005-05-20 | 2021-01-27 | Lonza Biologics plc. | Expression auf hohem niveau von rekombinantem antikörper in einer säugetier-wirtszelle |
| EP1907425B1 (de) | 2005-07-22 | 2014-01-08 | Y's Therapeutics Co., Ltd. | Anti-cd26-antikörper und verfahren zu ihrer verwendung |
| US9884899B2 (en) | 2007-07-06 | 2018-02-06 | Promedior, Inc. | Methods for treating fibrosis using CRP antagonists |
| KR102055873B1 (ko) | 2007-07-09 | 2019-12-13 | 제넨테크, 인크. | 폴리펩티드의 재조합 생산 동안의 디술피드 결합 환원의 방지 |
| UY32341A (es) | 2008-12-19 | 2010-07-30 | Glaxo Group Ltd | Proteínas de unión antígeno novedosas |
| CA2754961C (en) | 2009-03-11 | 2018-04-10 | Promedior, Inc. | Treatment and diagnostic methods for hypersensitive disorders |
| EP2405929B1 (de) | 2009-03-11 | 2018-06-06 | Promedior Inc. | Ein sap polypeptid zur verwendung in der behandlung von autoimmunerkrankungen und graft vers host reaktion |
| UA110323C2 (en) | 2009-06-04 | 2015-12-25 | Promedior Inc | Derivative of serum amyloid p and their receipt and application |
| EP2987803B1 (de) | 2009-06-17 | 2018-08-29 | Promedior Inc. | Sap-varianten und deren verwendung |
| HRP20200768T4 (hr) * | 2009-08-11 | 2025-03-28 | F. Hoffmann - La Roche Ag | Proizvodnja proteina u mediju za uzgoj stanica bez glutamina |
| WO2011080050A2 (en) | 2009-12-11 | 2011-07-07 | Novartis Ag | Binding molecules |
| PE20170687A1 (es) | 2010-01-28 | 2017-06-13 | Glaxo Group Ltd | Proteinas de enlace a cd127 |
| TWI622402B (zh) | 2010-02-24 | 2018-05-01 | 免疫遺傳股份有限公司 | 葉酸受體１抗體類和免疫共軛物類及彼等之用途 |
| UA108227C2 (xx) | 2010-03-03 | 2015-04-10 | Антигензв'язуючий білок | |
| SG10201501803YA (en) | 2010-03-12 | 2015-05-28 | Immunogen Inc | Cd37-binding molecules and immunoconjugates thereof |
| AR081556A1 (es) | 2010-06-03 | 2012-10-03 | Glaxo Group Ltd | Proteinas de union al antigeno humanizadas |
| JP5883443B2 (ja) | 2010-07-22 | 2016-03-15 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 新規の抗原結合タンパク質 |
| WO2012019024A2 (en) | 2010-08-04 | 2012-02-09 | Immunogen, Inc. | Her3-binding molecules and immunoconjugates thereof |
| CN103796681B (zh) | 2011-06-30 | 2018-07-20 | 建新公司 | T细胞活化的抑制剂 |
| JP6185463B2 (ja) | 2011-07-15 | 2017-08-23 | オンコメッド ファーマシューティカルズ インコーポレイテッド | Ｒｓｐｏ結合剤およびその使用法 |
| EP2734232B1 (de) | 2011-07-19 | 2017-11-01 | Philogen S.p.A. | Sequentielle anti-ctla4 und zielgerichtete il-2 therapie |
| UY34317A (es) | 2011-09-12 | 2013-02-28 | Genzyme Corp | Anticuerpo antireceptor de célula T (alfa)/ß |
| LT3485903T (lt) | 2011-09-23 | 2023-02-27 | Mereo Biopharma 5, Inc. | Vegf/ dll4 surišantys agentai ir jų panaudojimas |
| DK2797957T3 (da) | 2011-11-23 | 2019-09-23 | Medimmune Llc | Bindingsmolekyler specifikke for her3 og anvendelser deraf |
| EP3202419A1 (de) | 2012-06-06 | 2017-08-09 | OncoMed Pharmaceuticals, Inc. | Pvrig bindungsmittel zur modulation des hippo-pfads und verwendungen davon |
| EP2674495A1 (de) * | 2012-06-14 | 2013-12-18 | Sanofi | CHO-Expressionssystem |
| US9181333B2 (en) | 2012-07-13 | 2015-11-10 | Oncomed Pharmaceuticals, Inc. | RSPO3 binding agents and uses thereof |
| US9200073B2 (en) | 2012-08-31 | 2015-12-01 | Immunogen, Inc. | Diagnostic assays and kits for detection of folate receptor 1 |
| DK2711426T3 (en) | 2012-09-24 | 2015-07-13 | Lonza Biologics Plc | Expression vectors comprising chimeric cytomegalovirus promoter and enhancer sequences |
| HK1210964A1 (en) | 2012-12-04 | 2016-05-13 | Oncomed Pharmaceuticals, Inc. | Immunotherapy with binding agents |
| WO2014100073A2 (en) * | 2012-12-21 | 2014-06-26 | Merck Sharp & Dohme Corp. | Expression vectors for recombinant protein production in mammalian cells |
| CN113150145B (zh) | 2013-08-30 | 2025-02-14 | 伊缪诺金公司 | 用于检测叶酸受体1的抗体和测定 |
| WO2015069459A1 (en) | 2013-11-05 | 2015-05-14 | Novartis Ag | Organic compounds |
| CA2931975A1 (en) | 2013-12-02 | 2015-06-11 | Oncomed Pharmaceuticals, Inc. | Identification of predictive biomarkers associated with wnt pathway inhibitors |
| LT3099713T (lt) | 2014-02-02 | 2020-07-10 | Medimmune Limited | Chimerinis baltymas, sudarytas iš ngf antagonistinio domeno ir tnfa antagonistinio domeno |
| US8961992B1 (en) * | 2014-04-02 | 2015-02-24 | Tunitas Therapeutics, Inc. | Epsigam fusion protein |
| AU2015244025B2 (en) | 2014-04-08 | 2019-03-21 | Boston Pharmaceuticals Inc. | Binding molecules specific for IL-21 and uses thereof |
| SG11201608192SA (en) | 2014-04-11 | 2016-10-28 | Medimmune Llc | Bispecific her2 antibodies |
| WO2015165480A1 (en) | 2014-04-30 | 2015-11-05 | Institute For Research In Biomedicine | Human cytomegalovirus vaccine compositions and method of producing the same |
| EP3148573A4 (de) | 2014-05-29 | 2017-11-15 | Medimmune, LLC | Ox40l-fusionsproteine und verwendungen davon |
| WO2016011448A2 (en) * | 2014-07-18 | 2016-01-21 | Celltheon Corporation | Methods and compositions for expression of polypeptides in a cell |
| CN104195173B (zh) * | 2014-09-02 | 2017-03-08 | 北京比洋生物技术有限公司 | 具有双表达盒的谷氨酰胺合成酶高效表达载体 |
| TW201619200A (zh) | 2014-10-10 | 2016-06-01 | 麥迪紐有限責任公司 | 人類化抗－ｏｘ４０抗體及其用途 |
| WO2016059602A2 (en) | 2014-10-16 | 2016-04-21 | Glaxo Group Limited | Methods of treating cancer and related compositions |
| GB2537445A (en) | 2014-11-10 | 2016-10-19 | Medimmune Ltd | Binding molecules specific for CD73 and uses thereof |
| GB2538120A (en) | 2014-11-11 | 2016-11-09 | Medimmune Ltd | Therapeutic combinations comprising anti-CD73 antibodies and uses thereof |
| CN104561091A (zh) * | 2014-12-17 | 2015-04-29 | 华南理工大学 | 一种光学分析检测cho细胞增殖的方法及应用 |
| CN105779501A (zh) * | 2014-12-26 | 2016-07-20 | 上海药明康德新药开发有限公司 | 运用cho宿主细胞进行重组蛋白的瞬时表达生产的方法 |
| CN105802995A (zh) * | 2014-12-31 | 2016-07-27 | 上海复宏汉霖生物技术有限公司 | 一种利用cho细胞生产重组蛋白的基因表达系统及真核表达载体 |
| AU2016205188A1 (en) | 2015-01-09 | 2017-06-22 | Medimmune, Llc | Assay to detect human DPP-4 |
| ES2987442T3 (es) | 2015-05-04 | 2024-11-14 | Theriva Biologics S L | Adenovirus oncolíticos con mutaciones en epítopos de adenovirus inmunodominantes y su uso en el tratamiento del cáncer |
| JP7114460B2 (ja) | 2015-06-26 | 2022-08-08 | サノフィ・バイオテクノロジー | モノクローナル抗ＩＬ－１ＲＡｃＰ抗体 |
| AU2016285552B2 (en) | 2015-06-29 | 2022-10-13 | Immunogen, Inc. | Anti-CD123 antibodies and conjugates and derivatives thereof |
| JP2018522571A (ja) | 2015-08-12 | 2018-08-16 | メディミューン リミテッド | Ｇｉｔｒｌ融合タンパク質およびその使用 |
| US11339213B2 (en) | 2015-09-23 | 2022-05-24 | Mereo Biopharma 5, Inc. | Methods and compositions for treatment of cancer |
| EP4530350A3 (de) | 2015-10-09 | 2025-06-25 | Genzyme Corporation | Verbesserte fackeltechnologie (durchflusszytometriegedämpfte reporterexpression) für schnelle massensortierung |
| MY192146A (en) | 2015-11-10 | 2022-08-01 | Medimmune Llc | Binding molecules specific for asct2 and uses thereof |
| CN116284392A (zh) | 2016-03-10 | 2023-06-23 | 艾科赛扬制药股份有限公司 | 活化素2型受体结合蛋白及其用途 |
| KR102444717B1 (ko) | 2016-04-15 | 2022-09-16 | 하. 룬드벡 아크티에셀스카브 | 인간화 항-pacap 항체 및 그의 용도 |
| WO2017185037A1 (en) | 2016-04-22 | 2017-10-26 | Acceleron Pharma Inc. | Alk7 binding proteins and uses thereof |
| US20180126000A1 (en) | 2016-06-02 | 2018-05-10 | Abbvie Inc. | Glucocorticoid receptor agonist and immunoconjugates thereof |
| CA3039598A1 (en) | 2016-10-07 | 2018-04-12 | Genzyme Corporation | Early post-transfection isolation of cells (epic) for biologics production |
| WO2018071345A1 (en) | 2016-10-11 | 2018-04-19 | Integrated Biotherapeutics, Inc. | Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop |
| TN2019000164A1 (en) | 2016-11-23 | 2020-10-05 | Bioverativ Therapeutics Inc | Mono- and bispecific antibodies binding to coagulation factor ix and coagulation factor x |
| CN107973841B (zh) * | 2016-12-23 | 2022-03-25 | 浙江海隆生物科技有限公司 | Cho细胞表达的重组牛病毒性腹泻病毒e2蛋白及亚单位疫苗的制备方法和应用 |
| JP7467119B2 (ja) | 2017-02-17 | 2024-04-15 | ロンザ リミテッド | 発現困難タンパク質のための多部位ｓｓｉ細胞 |
| GB201703418D0 (en) | 2017-03-03 | 2017-04-19 | Ge Healthcare Bio Sciences Ab | Method for cell line development |
| US12054733B2 (en) | 2017-06-16 | 2024-08-06 | Lonza Ltd | Universal self-regulating mammalian cell line platform for the production of biologics |
| BR112020010694A2 (pt) | 2017-12-01 | 2020-11-10 | Abbvie Inc. | agonista de receptor de glicocorticoides e imunoconjugados do mesmo |
| EP3902824A4 (de) | 2018-12-28 | 2023-01-04 | Sparx Therapeutics Inc. | Für claudin 18.2 spezifische bindungsmoleküle, zusammensetzungen und verfahren zur behandlung von krebs und anderen krankheiten |
| CN120192414A (zh) | 2019-04-03 | 2025-06-24 | 建新公司 | 具有降低的断裂的抗αβTCR结合多肽 |
| WO2020257281A1 (en) | 2019-06-18 | 2020-12-24 | United Therapeutics Corporation | Mitochondrial treatment of organs for transplantation |
| CN113005140B (zh) * | 2019-12-19 | 2024-03-15 | 鲁南制药集团股份有限公司 | 一种具有双表达盒的gs表达载体及其应用 |
| WO2021247672A1 (en) * | 2020-06-02 | 2021-12-09 | Catalent Pharma Solutions, Llc | Nucleic acid constructs for protein manufacture |
| EP4186526A4 (de) | 2020-06-08 | 2024-09-25 | Y'S AC Co., Ltd. | Mittel zur umkehrung der resistenz gegen antikrebsmittel |
| KR20230084199A (ko) | 2020-09-28 | 2023-06-12 | 메디뮨 리미티드 | 통증 치료를 위한 화합물 및 방법 |
| WO2022255248A1 (ja) | 2021-05-31 | 2022-12-08 | ワイズ・エー・シー株式会社 | 抗ｃｄ２６抗体と免疫チェックポイント阻害剤との併用療法 |
| US11807685B2 (en) | 2021-08-05 | 2023-11-07 | The Uab Research Foundation | Anti-CD47 antibody and uses thereof |
| US20240425572A1 (en) | 2021-10-15 | 2024-12-26 | Regenxbio Inc. | Antibodies and methods of using thereof |
| AR130550A1 (es) | 2022-09-21 | 2024-12-18 | Sanofi Biotechnology | Anticuerpo anti-il-1r3 humanizado y métodos de uso |
| WO2024169990A1 (zh) | 2023-02-13 | 2024-08-22 | 浙江大学绍兴研究院 | 双特异性抗体及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2944850A1 (de) * | 1979-11-07 | 1981-05-27 | Bayer Ag, 5090 Leverkusen | Mittel zur regulierung des pflanzenwachstums, deren herstellung und deren verwendung |
| US4963481A (en) * | 1985-12-18 | 1990-10-16 | Genetics Institute Inc | Promoter system |
| US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US5891693A (en) * | 1990-01-25 | 1999-04-06 | Alusuisse Holdings A.G. | Recombinant DNA methods vectors and host cells |
| IT1262545B (it) | 1993-10-25 | 1996-07-02 | Menarini Ricerche Sud S P A A | Sistema di espressione per linee cellulari eucariotiche |
| ATE244311T1 (de) * | 1993-12-23 | 2003-07-15 | Merck & Co Inc | Expressionssystem von antikörpern bei homologischer rekombinierung in murinezellen |
| JP3379758B2 (ja) | 1994-02-07 | 2003-02-24 | クイアジェン・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | イソプロパノール含有水溶液を用いる核酸のトランスフェクション効率の増強 |
| GB0216648D0 (en) * | 2002-07-18 | 2002-08-28 | Lonza Biologics Plc | Method of expressing recombinant protein in CHO cells |
| US7824907B2 (en) | 2003-03-11 | 2010-11-02 | Merck Serono Sa | Expression vectors comprising the mCMV IE2 promoter |
-
2002
- 2002-07-18 GB GBGB0216648.6A patent/GB0216648D0/en not_active Ceased
-
2003
- 2003-07-21 AT AT03765075T patent/ATE412761T1/de active
- 2003-07-21 US US10/521,768 patent/US20060003405A1/en not_active Abandoned
- 2003-07-21 DE DE60324430T patent/DE60324430D1/de not_active Expired - Lifetime
- 2003-07-21 AU AU2003251434A patent/AU2003251434B2/en not_active Expired
- 2003-07-21 ES ES03765075T patent/ES2314248T3/es not_active Expired - Lifetime
- 2003-07-21 CN CNB038169142A patent/CN1296486C/zh not_active Expired - Lifetime
- 2003-07-21 CA CA2489016A patent/CA2489016C/en not_active Expired - Lifetime
- 2003-07-21 PT PT03765075T patent/PT1525320E/pt unknown
- 2003-07-21 EP EP03765075A patent/EP1525320B1/de not_active Expired - Lifetime
- 2003-07-21 CA CA2672809A patent/CA2672809C/en not_active Expired - Lifetime
- 2003-07-21 SI SI200331477T patent/SI1525320T1/sl unknown
- 2003-07-21 DK DK03765075T patent/DK1525320T3/da active
- 2003-07-21 WO PCT/EP2003/007946 patent/WO2004009823A1/en not_active Ceased
-
2007
- 2007-12-21 US US11/962,261 patent/US7932087B2/en not_active Expired - Lifetime
-
2009
- 2009-02-19 AU AU2009200665A patent/AU2009200665B2/en not_active Expired
-
2010
- 2010-12-10 US US12/964,918 patent/US20110104745A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009200665B2 (en) | 2012-08-16 |
| SI1525320T1 (sl) | 2009-02-28 |
| US7932087B2 (en) | 2011-04-26 |
| CA2489016C (en) | 2012-01-17 |
| ES2314248T3 (es) | 2009-03-16 |
| EP1525320A1 (de) | 2005-04-27 |
| CA2489016A1 (en) | 2004-01-29 |
| AU2009200665A1 (en) | 2009-03-12 |
| CN1296486C (zh) | 2007-01-24 |
| WO2004009823A1 (en) | 2004-01-29 |
| US20110104745A1 (en) | 2011-05-05 |
| CA2672809C (en) | 2013-01-08 |
| EP1525320B1 (de) | 2008-10-29 |
| HK1081595A1 (en) | 2006-05-19 |
| AU2003251434A1 (en) | 2004-02-09 |
| DE60324430D1 (de) | 2008-12-11 |
| GB0216648D0 (en) | 2002-08-28 |
| DK1525320T3 (da) | 2009-02-23 |
| AU2003251434B2 (en) | 2009-03-05 |
| US20060003405A1 (en) | 2006-01-05 |
| PT1525320E (pt) | 2009-01-23 |
| US20080138902A1 (en) | 2008-06-12 |
| CN1668749A (zh) | 2005-09-14 |
| CA2672809A1 (en) | 2004-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE412761T1 (de) | Methode um rekombinante proteine in cho zellen zu exprimieren | |
| CY1107014T1 (el) | Χρηση θρεπτικου μεσου κυτταροκαλλιεργειας ελευθερου ορου για την παραγωγη il-18bp σε κυτταρα θηλαστικων | |
| EP2536821A4 (de) | Verbesserung der wirkung von fe-s-bündel erfordernden proteinen | |
| BRPI0411475A (pt) | adições de código genético de aminoácido reativo não natural | |
| MX2010001319A (es) | Metodo para producir proteinas heterogeneas. | |
| DE60233147D1 (de) | Verwendung von hmgb1 zur aktivierung dendritischer zellen | |
| MX2010007729A (es) | Vectores de expresion de mamifero mejorados y uso de los mismos. | |
| NO20076087L (no) | Serum-fri stabil transfeksjon og fremstilling av rekombinante humane proteiner i humane cellelinjer | |
| DK1697523T3 (da) | Ekspressionsvektor til antibiotikafri ekspression | |
| DK1549735T3 (da) | Cirkulært DNA-molekyle med et konditionelt replikationsstartssted, fremgangsmåde til fremstilling heraf og anvendelse af disse til genterapi | |
| Reitter et al. | Salt-dependent conditional protein splicing of an intein from Halobacterium salinarum | |
| ATE474926T1 (de) | Verwendung von clya hemolysin fur ausscheidung von fusionprotein | |
| EA202091349A1 (ru) | Способы культивирования клеток | |
| DE60307615D1 (de) | Zellkulturmedium | |
| ATE448312T1 (de) | Leitsequenzen zur verwendung bei der produktion von proteinen | |
| ATE526394T1 (de) | Verfahren zur expansion von cd4+ cd25+ t regulatory zellen | |
| UA92157C2 (ru) | Способ продуцирования гормона роста | |
| DK2010565T3 (da) | Fremgangsmåde til produktion af rekombinant protein i CHO-celler | |
| ATE527349T1 (de) | Nervenregeneration | |
| DK1743029T3 (da) | Cellefremstilling | |
| DK1572133T3 (da) | Fremgangsmåde til identificering af modulatorer af den humane orexin-2-receptor | |
| MXPA05008231A (es) | Vector de alta expresion para celulas animales. | |
| ATE469920T1 (de) | Herstellung von rekombinanten igm in den per.c6 zellen | |
| CY1111412T1 (el) | Μεσο καλλιεργειας κυτταρων ελευθερο ορου για κυτταρα θηλαστικων | |
| KR100717353B1 (ko) | 피키아 파스토리스 유래의 자동 유도성 ｎｐｓ 프로모터 및이를 이용한 이종 단백질의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1525320 Country of ref document: EP |